Product Images Vilazodone Hydrochloride

This text provides information about Vilazodone Hydrochloride Tablets. Each tablet contains 10 mg of vilazodone hydrochloride and should be stored between 15° to 30°C. The manufacturer is Alembic Pharmaceuticals Limited and the product is dispensed in a tightly closed container. The NDC number is 46708-232-30, and it is available in a package of 30 tablets. The pharmacist is required to dispense the accompanying medication guide to each patient. The rest of the text contains manufacturing details and a lot/expiry date that has been omitted.*

Each film-coated tablet contains 20 mg of vilazodone hydrochloride. Store between 15° to 30°C (59° to 86°F). The usual dosage is indicated in the package insert. Dispense in a tightly closed container and keep out of reach of children. Manufactured by Alembic Pharmaceuticals in Gujarat, India. The tablets are identified by the NDC code 46708-233-30 and the lot and expiration date should be checked before use. A Medication Guide should be dispensed to each patient by the pharmacist. This product is for prescription use only.*

This is a description of a medication called Vilazodone Hydrochloride Tablets. Each tablet contains 40mg of Vilazodone Hydrochloride and should be stored within the recommended temperature range. The dosage is indicated in the package insert, and the medication should always be kept in a tightly closed container, out of reach of children. The product is manufactured by Alembic Pharmaceuticals Limited in India and is available in 30 tablet packages. It's advised that the accompanying medication guide is given to each patient by a pharmacist. The lot number and expiration date are not provided in the text.*

This text is a description of the population used in a study, including fold change and 90% confidence intervals based on different demographic and health-related factors such as age, gender, and renal/hepatic impairment. It also provides information on how the data is presented and how it relates to reference values.*

This is a table showing the impact of Vilazodone on the pharmacokinetics of various drugs that are substrates of different enzymes and transporters in the body. The changes in pharmacokinetic parameters such as AUC, plasma concentration, urinary recovery, and renal clearance are expressed as fold change and 90% confidence intervals. The drugs include nifedipine, caffeine, debrisoquine, flurbiprofen, mephenytoin, and digoxin. The enzymes and transporters involved in their metabolism include CYP3A4, CYP1A2, CYP2A6, CYP2A9, CYP2A19, and P-glycoprotein.*

This text appears to be a figure caption for a graph or table showing the effect of various drugs on vilazodone pharmacokinetics. The drugs listed include ethanol, CYP3A4 inhibitors (such as ketoconazole), CYP3A4 inducers (such as carbamazepine), and proton pump inhibitors (such as pantoprazole). The graph or table likely shows fold change and 90% confidence intervals for changes in PK (pharmacokinetics) and AUC (area under the curve) of vilazodone. Unfortunately, without the graph or table itself, it is difficult to provide more detailed information.*